Everything you need to know about investing in Unlisted / Pre-IPO shares
A Detailed Analysis Of CSK’s Financial Statement For The FY 22-23
Total revenue of CSK for FY 22-23 was Rs. 29234
A Comparison Of HDB Financial Services Annual Report Of FY22 And FY23
HDB Financial Services shared its FY 22-23 annual report with
Religare May Sell Its 7% Of Health Insurance Business: What Does It Indicate For Investors?
Religare Health Insurance company is in the limelight to sell
Bira 91 Operating Revenue Increased By 1.7 Times In FY22- What It Signifies?
Bira91’s operating revenue in FY22 increased by 1.7 times, showing
A Detailed Analysis Of Religare Financial Statements For The FY 2022-2023
Specialised in health insurance, Religare unlisted shares prices have recently
IXIGO’s Possible Strategies To Raise New Funds Ahead Of Its IPO
Ixigo, India’s online travel aggregator, has been in the headlines
A Comparative Analysis Of Studds And Its Competitors In The Last 5 Years
Riding a two-wheeler with a sturdy and advanced helmet becomes
Hero Fincorp Is In Talks With I-Banks To Raise Rs 4,000 Crore For Its IPO
Hero Fincorp, a subsidiary of India’s largest two-wheeler maker, Hero
NSE Recorded 35% CAGR Growth In Revenue And Net Profit- How It Can Bring Multibagger Returns For Investors?
Investing in the stock exchange in India seems like being
NSE Announced A Dividend Share For Investors- A Simplified Explanation For Retail Investors
NSE, India’s leading stock exchange, recently announced a dividend share
Navigating The Liquidity Risk Involved In NSE Unlisted Shares
Unlisted share or grey market has always been a topic
PharmEasy Plans To Raise Rs 2,000-3,000 Crore via Its Rights Issue
API Holdings Ltd, a parent company of PharmEasy, is planning
